Matches in SemOpenAlex for { <https://semopenalex.org/work/W2071411087> ?p ?o ?g. }
- W2071411087 endingPage "1084" @default.
- W2071411087 startingPage "1084" @default.
- W2071411087 abstract "Attention-deficit/hyperactivity disorder (ADHD)--characterized by symptoms of inattention and hyperactivity-impulsivity--is the most prevalent childhood psychiatric disorder that frequently persists into adulthood, and there is increasing evidence of reward-motivation deficits in this disorder.To evaluate biological bases that might underlie a reward/motivation deficit by imaging key components of the brain dopamine reward pathway (mesoaccumbens).We used positron emission tomography to measure dopamine synaptic markers (transporters and D(2)/D(3) receptors) in 53 nonmedicated adults with ADHD and 44 healthy controls between 2001-2009 at Brookhaven National Laboratory.We measured specific binding of positron emission tomographic radioligands for dopamine transporters (DAT) using [(11)C]cocaine and for D(2)/D(3) receptors using [(11)C]raclopride, quantified as binding potential (distribution volume ratio -1).For both ligands, statistical parametric mapping showed that specific binding was lower in ADHD than in controls (threshold for significance set at P < .005) in regions of the dopamine reward pathway in the left side of the brain. Region-of-interest analyses corroborated these findings. The mean (95% confidence interval [CI] of mean difference) for DAT in the nucleus accumbens for controls was 0.71 vs 0.63 for those with ADHD (95% CI, 0.03-0.13, P = .004) and in the midbrain for controls was 0.16 vs 0.09 for those with ADHD (95% CI, 0.03-0.12; P < or = .001); for D(2)/D(3) receptors, the mean accumbens for controls was 2.85 vs 2.68 for those with ADHD (95% CI, 0.06-0.30, P = .004); and in the midbrain, it was for controls 0.28 vs 0.18 for those with ADHD (95% CI, 0.02-0.17, P = .01). The analysis also corroborated differences in the left caudate: the mean DAT for controls was 0.66 vs 0.53 for those with ADHD (95% CI, 0.04-0.22; P = .003) and the mean D(2)/D(3) for controls was 2.80 vs 2.47 for those with ADHD (95% CI, 0.10-0.56; P = .005) and differences in D(2)/D(3) in the hypothalamic region, with controls having a mean of 0.12 vs 0.05 for those with ADHD (95% CI, 0.02-0.12; P = .004). Ratings of attention correlated with D(2)/D(3) in the accumbens (r = 0.35; 95% CI, 0.15-0.52; P = .001), midbrain (r = 0.35; 95% CI, 0.14-0.52; P = .001), caudate (r = 0.32; 95% CI, 0.11-0.50; P = .003), and hypothalamic (r = 0.31; CI, 0.10-0.49; P = .003) regions and with DAT in the midbrain (r = 0.37; 95% CI, 0.16-0.53; P < or = .001).A reduction in dopamine synaptic markers associated with symptoms of inattention was shown in the dopamine reward pathway of participants with ADHD." @default.
- W2071411087 created "2016-06-24" @default.
- W2071411087 creator A5002969658 @default.
- W2071411087 creator A5010123075 @default.
- W2071411087 creator A5017360650 @default.
- W2071411087 creator A5029493957 @default.
- W2071411087 creator A5036802141 @default.
- W2071411087 creator A5038672981 @default.
- W2071411087 creator A5041283393 @default.
- W2071411087 creator A5049748393 @default.
- W2071411087 creator A5055440086 @default.
- W2071411087 creator A5055941537 @default.
- W2071411087 creator A5057328085 @default.
- W2071411087 creator A5068191739 @default.
- W2071411087 creator A5081492952 @default.
- W2071411087 date "2009-09-09" @default.
- W2071411087 modified "2023-10-17" @default.
- W2071411087 title "Evaluating Dopamine Reward Pathway in ADHD" @default.
- W2071411087 cites W1493538977 @default.
- W2071411087 cites W1574826837 @default.
- W2071411087 cites W164735932 @default.
- W2071411087 cites W1749013520 @default.
- W2071411087 cites W1821065636 @default.
- W2071411087 cites W1896744728 @default.
- W2071411087 cites W1964497838 @default.
- W2071411087 cites W1977761077 @default.
- W2071411087 cites W1981830992 @default.
- W2071411087 cites W1983332126 @default.
- W2071411087 cites W1983779361 @default.
- W2071411087 cites W1984719574 @default.
- W2071411087 cites W1988760898 @default.
- W2071411087 cites W1991887155 @default.
- W2071411087 cites W1994249945 @default.
- W2071411087 cites W2010667681 @default.
- W2071411087 cites W2015402194 @default.
- W2071411087 cites W2015465857 @default.
- W2071411087 cites W2021311177 @default.
- W2071411087 cites W2023504580 @default.
- W2071411087 cites W2029099271 @default.
- W2071411087 cites W2030495744 @default.
- W2071411087 cites W2032731486 @default.
- W2071411087 cites W2041371320 @default.
- W2071411087 cites W2043537094 @default.
- W2071411087 cites W2052171450 @default.
- W2071411087 cites W2055561209 @default.
- W2071411087 cites W2058314608 @default.
- W2071411087 cites W2062608310 @default.
- W2071411087 cites W2063017390 @default.
- W2071411087 cites W2064260924 @default.
- W2071411087 cites W2072775036 @default.
- W2071411087 cites W2076464627 @default.
- W2071411087 cites W2082738856 @default.
- W2071411087 cites W2088014919 @default.
- W2071411087 cites W2097559385 @default.
- W2071411087 cites W2098273438 @default.
- W2071411087 cites W2115518880 @default.
- W2071411087 cites W2119279880 @default.
- W2071411087 cites W2120871408 @default.
- W2071411087 cites W2123547278 @default.
- W2071411087 cites W2125080419 @default.
- W2071411087 cites W2130141507 @default.
- W2071411087 cites W2132921554 @default.
- W2071411087 cites W2135691106 @default.
- W2071411087 cites W2143384791 @default.
- W2071411087 cites W2148713298 @default.
- W2071411087 cites W2148955566 @default.
- W2071411087 cites W2149745184 @default.
- W2071411087 cites W2152929067 @default.
- W2071411087 cites W2156590529 @default.
- W2071411087 cites W2157406338 @default.
- W2071411087 cites W2163069501 @default.
- W2071411087 cites W2163773342 @default.
- W2071411087 cites W2169366712 @default.
- W2071411087 cites W2171630510 @default.
- W2071411087 cites W2174764226 @default.
- W2071411087 cites W2989610730 @default.
- W2071411087 doi "https://doi.org/10.1001/jama.2009.1308" @default.
- W2071411087 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2958516" @default.
- W2071411087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19738093" @default.
- W2071411087 hasPublicationYear "2009" @default.
- W2071411087 type Work @default.
- W2071411087 sameAs 2071411087 @default.
- W2071411087 citedByCount "540" @default.
- W2071411087 countsByYear W20714110872012 @default.
- W2071411087 countsByYear W20714110872013 @default.
- W2071411087 countsByYear W20714110872014 @default.
- W2071411087 countsByYear W20714110872015 @default.
- W2071411087 countsByYear W20714110872016 @default.
- W2071411087 countsByYear W20714110872017 @default.
- W2071411087 countsByYear W20714110872018 @default.
- W2071411087 countsByYear W20714110872019 @default.
- W2071411087 countsByYear W20714110872020 @default.
- W2071411087 countsByYear W20714110872021 @default.
- W2071411087 countsByYear W20714110872022 @default.
- W2071411087 countsByYear W20714110872023 @default.
- W2071411087 crossrefType "journal-article" @default.
- W2071411087 hasAuthorship W2071411087A5002969658 @default.
- W2071411087 hasAuthorship W2071411087A5010123075 @default.